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SUMMARY
Bovine tuberculosis (BTB), caused by Mycobacterium
bovis, has an annual incidence in cattle of 0.5% in the
Republic of Ireland and 4.7% in the UK, despite long-stand-
ing eradication programmes being in place. Failure to
achieve complete eradication is multifactorial, but the limi-
tations of diagnostic tests are significant complicating fac-
tors. Previously, we have demonstrated that Fasciola
hepatica infection, highly prevalent in these areas, induced
reduced sensitivity of the standard diagnostic tests for BTB
in animals co-infected with F. hepatica and M. bovis. This
was accompanied by a reduced M. bovis-specific Th1
immune response. We hypothesized that these changes in
co-infected animals would be accompanied by enhanced
growth of M. bovis. However, we show here that mycobacte-
rial burden in cattle is reduced in animals co-infected with
F. hepatica. Furthermore, we demonstrate a lower mycobacte-
rial recovery and uptake in blood monocyte-derived macro-
phages (MDM) from F. hepatica-infected cattle which is
associated with suppression of pro-inflammatory cytokines
and a switch to alternative activation of macrophages. How-
ever, the cell surface expression of TLR2 and CD14 in MDM
from F. hepatica-infected cattle is increased. These findings
reflecting the bystander effect of helminth-induced downregu-
lation of pro-inflammatory responses provide insights to
understand host-pathogen interactions in co-infection.
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INTRODUCTION
The control of infectious diseases within populations,
whether through vaccination programmes and/or identifi-
cation and removal of infected individuals, is dependent
on immune responsiveness to the pathogens concerned.
Immune responsiveness to a particular pathogen within a
population is subject to modulation by a multitude of fac-
tors including host genetics (1–3), reproductive cycles and
the presence of co-infections (4). Such factors are easily
controlled in experimental studies, but they may have a
significant impact in the real world of naturally occurring
infection (5–8). Parasitic helminths, ubiquitous in grazing
livestock and common in humans in many parts of the
world, typically use immunoregulatory strategies to
achieve persistent infections, while reducing inflammatory
pathology in the host (9,10). They also have the potential,
through bystander immunoregulation, to alter the pathol-
ogy and course of other infections in the same host (11–
16). Here, we model some aspects of the interaction
between a helminth and a bacterial pathogen, both of
which cause economically important diseases of livestock.
The liver fluke, Fasciola hepatica, is a highly prevalent
helminth parasite of farmed ruminants (17), estimated to
cause annual losses of about €2.5 billion annually to the
livestock industry worldwide. F. hepatica also affects a
wide range of other mammals, including humans, with
approximately 170 million people at risk of infection (18).
Mycobacterium bovis, the causative agent of bovine tuber-
culosis (BTB), also has zoonotic implications; as an
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estimate, 3.1% of human tuberculosis cases globally are
caused by M. bovis (19). In some developed countries,
eradication programmes have reduced or eliminated BTB.
However, reservoirs of M. bovis in wildlife (20–22),
together with the limitations of diagnostic tests (23), have
made complete eradication difficult in others (24).
In previous studies, we have shown that two diagnostic
tests used in BTB eradication schemes, the single intra-
dermal comparative cervical tuberculin test (SICCT) and
the in vitro interferon (IFN)-c assay, were between 50%
and 80% less effective in detecting M. bovis-infected cattle
when the animals were co-infected with F. hepatica
(25,26), leading to a lower positive predictive value of the
tests. This was also shown in a large-scale epidemiological
study in England and Wales, where dairy herds with a
high prevalence of F. hepatica infection had a lower num-
ber of BTB reactors (6). This reduced sensitivity of the
diagnostic tests was hypothesized to be due to an
immunosuppression induced by F. hepatica infection. A
downregulation of the Th1 immune response in other co-
infection models has been associated with an increase in
bacterial loads (14–16,27). Thus, we proposed that these
changes in F. hepatica-infected animals might also result
in an increase in the M. bovis numbers in co-infected
animals.
Previously, it has been shown that CD14 played a major
role in phagocytosis of M. bovis BCG by macrophages,
and optimal uptake required the presence of both CD14
and complement receptor 3 (CR3). In addition, co-expres-
sion of CD14 and TLR2 markedly enhanced uptake of
BCG (28). Other studies have shown the importance of
these receptors in mycobacterial phagocytosis (29,30) and
immune responsiveness (31,32). Thus, given that expression
of these receptors might vary after infection with helminths
(33), we proposed that TLR2 and CD14 could be modified
in macrophages from F. hepatica-infected cattle, leading to
alterations in mycobacterial uptake and recovery from such
macrophages. Next, we investigated the cytokine profile
and the activation of macrophages in vitro after F. hepatica
infection of cattle. Alternatively activated macrophages,
known to develop in F. hepatica infections (34,35), are not
efficient at bacterial phagocytosis (36). In addition, these
alternatively activated macrophages are characterized by
the production of Th2 and Treg cytokines and a reduced
production of Th1 cytokines. Some of these pro-inflamma-
tory cytokines such as IL-12, IL-1b and IL-6 directly affect
IFN-c production (37–39) and the immune response in the
SICCT (40), the two standard tests for the diagnosis of
BTB in Europe. Thus, we hypothesized that an alteration
in the pro-inflammatory cytokine profile in MDM from
F. hepatica-infected cattle could relate to a modified bacte-
rial uptake as well as explaining the lower response to the
diagnostic tests for BTB in animals co-infected with M. bo-
vis and F. hepatica.
MATERIALS AND METHODS
Experimental design
For the co-infection experiments (experiments 1 and 2),
male castrated Holstein–Friesian cattle aged between 3
and 7 weeks of age (12 animals for each experiment) were
purchased from farms known to be TB-free, as determined
by the official tuberculosis eradication programme in the
UK, and where fasciolosis had not been reported. Animals
were housed in Containment Level 3 (CL3) facilities at
AFBI (Stormont, Belfast, UK) as described by Flynn
et al. (26). Animals were then randomly divided into two
groups and assigned to M. bovis-only-infected group
(n = 6) or the F. hepatica–M. bovis-infected group (n = 6),
in order to compare mycobacterial burden. Blood was col-
lected weekly to measure IFN-c production until week 14
(Experiment 1) and week 22 (Experiment 2).
For the in vitro experiment (Experiment 3), six male cas-
trated Holstein–Friesian calves aged between 6 and
8 months of age were purchased from herds free of BTB
and where F. hepatica infection was not reported. Animals
were maintained under uniform housing conditions at
University College Dublin (UCD) Lyons Research Farm
(Newcastle, County Kildare, Ireland). All six animals were
infected with F. hepatica, and mycobacterial recovery and
uptake, TLR2 and CD14 receptor expression and cytokine
production from MDM, compared prior to and after
F. hepatica infection.
Experiments 1 and 2 were approved/licensed by the Ani-
mal Scientific Procedures Act 1986 (DHSSPS) under the
scrutiny of the Animal Welfare and Ethical Review Body
(AWERB), PPL2728, Agri-Food and Biosciences Institute,
Belfast, UK. Experiment 3 was approved/licensed by the
UCD Animal Research Ethics Committee/Health Products
Regulatory Agency (AE18982/P023), University College
Dublin, Ireland.
Experimental F. hepatica infection of cattle
In all experiments, to ensure that animals were free from
F. hepatica infection before starting the study, animals
were serologically screened by ELISA using recombinant
mutant F. hepatica cathepsin L1 (rmFhCL1), as previously
described (35), and by faecal egg examination. For F. hep-
atica infection, 150 F. hepatica metacercariae (Baldwin
Aquatics, (Oregon)), dispersed in 10 mL of dH2O, were
administered orally via a syringe onto the back of the ton-
gue. For confirmation of infection, numbers of parasites
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in the liver of each animal in Experiment 1 (26) and Exper-
iment 2 (Table S1) were recorded. In addition, specific anti-
body responses to F. hepatica infection were measured and
no effect of M. bovis infection on such antibody levels to
F. hepatica was observed in Experiment 1 (26) or Experi-
ment 2 (data not shown). For Experiment 3, post-mortem
examinations were not carried out, but seroconversion for
F. hepatica infection using recombinant cathepsin-like 1
(rmFhCL1) by ELISA (Figure S1) was monitored as previ-
ously described (35).
Bacterial strains and bacterial stocks
In all three experiments, Mycobacterium bovis AF2122/97,
a UK isolate, was used. For Experiment 3, in addition,
the nonvirulent M. bovis BCG-GFP Pasteur was used. All
the work involving virulent M. bovis was performed in a
Biosafety Containment Level 3 (CL3) laboratory and con-
formed to guidelines on the use of Hazard Group 3 infec-
tious organisms.
M. bovis was cultured in Middlebrook 7H9 medium
(DifcoTM, Becton Dickinson) containing 10% Middle-
brook albumin–dextrose–catalase (ADC) enrichment 5%
BSA (Fisher Chemical), 111 mM glucose (GPR), 145.4 mM
NaCl (Fluka BioChemika)) and 10 mM sodium pyruvate
(Sigma–Aldrich) at 37°C. Bacterial cultures were grown to
logarithmic phase (O.D = 1). To achieve this, 1 mL of
bacterial frozen aliquot was diluted in 4 mL of Middle-
brook 7H9 medium in a 50-mL Falcon tube and incu-
bated at 37°C in static conditions for 5 days. Then,
cultures were scaled up by adding the 5 mL of bacterial
culture to 45 mL of Middlebrook 7H9 medium into an
Erlenmeyer flask (Corning) and incubated at 37°C for
further 2 weeks.
Experimental M. bovis infection of cattle
For co-infection experiments (experiments 1 and 2), all
animals were prescreened for immunological responses to
the M. bovis antigens PPDA, PPDB, ESAT-6 and CFP-10
to ensure that there was no pre-existing exposure. All ani-
mals were housed in Containment Level 3 facilities under
negative air pressure at AFBI Veterinary Sciences Divi-
sion, Stormont. At 4 weeks post-F. hepatica infection, ani-
mals were exposed to low-dose aerosol challenge with
M. bovis using a Madison chamber modified for use with
cattle as previously described (41). The intended target
infection dose was 5 9 102 colony-forming units (CFU) of
M. bovis strain AF2122/99, which has been demonstrated
to be infective in animals while mimicking the natural
infection (42). Actual doses delivered were calculated by
side-flow sampling from the Madison chambers, and there
were no statistically significant differences between deliv-
ered doses between groups (See Table S2 of Supporting
Information).
IFN-c test
For the co-infection experiments (experiments 1 and 2),
IFN-c production was measured in whole blood cultures
after stimulation with PPDB-PPDA and ESAT-6 antigens,
using the Bovigam Kit as per manufacturer’s instructions.
Post-mortem examination
Fourteen (Experiment 1) or 22 (Experiment 2) weeks after
F. hepatica infection, the animals were euthanized and
samples from each lung lobe, right and left bronchial
lymph nodes, along with hepatic and cervical lymph
nodes, were collected. Lungs were palpated by hand and
then sliced at 1-cm intervals to reveal any tuberculous tis-
sue. Each tissue sample was dissected carefully to reveal
lesions indicative of tuberculosis, which were counted and
measured. Lesions or suspect lesions, together with the
other tissues, were sliced into cubes measuring approxi-
mately 5 mm in diameter and sent for bacteriology for
preparation of cultures (see details below) and for histol-
ogy processing as previously described (43,44).
For confirmation of F. hepatica infection, each liver
was carefully sliced at 1-cm intervals. The bile ducts were
squeezed to extrude any contained fluke. After dissection,
the cubes of liver tissue were placed inside two layers of
muslin cloth, soaked in water and squeezed several times.
The inside of the cloth was then rinsed in water to
remove flukes. All flukes were fixed in formaldehyde
for microscopic verification of fluke morphology and
counting.
Bacterial recovery from tissues
For experiments 1 and 2, the cubed tissue samples were
placed into double-thickness stomacher bags with between
4 and 15 mL PBS and homogenized in a stomacher at
maximum speed for 2 min. Tissue homogenates were dec-
anted into sterile universal bottles for inoculation into
media for qualitative and quantitative cultures.
Qualitative culture
For qualitative culture, tissue homogenates were inoculated
into the BACTEC MGIT 960 culture system and incu-
bated for up to 56 days. Samples identified as positive by
the BACTEC MGIT 960 system were stained using the
Ziehl–Neelsen method for confirmation purposes. Samples
containing typical acid-fast rods were presumed to be
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positive for M. bovis and analysed further by VNTR to
identify the infection strain (AF2122/97).
Quantitative culture
For quantitative culture, tissue homogenates were decon-
taminated in 0.075% hexadecylpyridinium chloride (HPC).
Hundred microlitres of this was serially diluted and inocu-
lated in quadruplicate onto 7H11-OADC agar plates and
incubated at 37°C for up to 6 weeks. M. bovis colonies
were counted weekly from 3 weeks onwards and the aver-
age colony counts at 6 weeks post-inoculation used to cal-
culate the total number of CFU per gram of sample.
M. bovis colonies were initially identified on the basis
of colony morphology and a selection of colonies was
prepared for VNTR typing to confirm isolation of
AF2122/97.
Isolation of monocyte-derived macrophages (MDM)
For Experiment 3, 300 mL of blood was collected per
each of the 6 animals, into lithium heparin vacutainers
(Cruinn Diagnostics), pre-F. hepatica infection and at 4, 8
and 10 weeks post-F. hepatica infection. Then, peripheral
blood mononuclear cells (PBMC) were isolated by the
density gradient centrifugation method using Histopaque
(Sigma–Aldrich). Next, anti-CD14+ microbeads (Miltenyi
Biotec) were used to isolate monocytes as per manufac-
turer’s instructions (detailed protocol in Supporting
Information Page 17). Cell viability was checked with try-
pan blue (Sigma–Aldrich), and selected CD14+ cells were
adjusted to 1 9 106 cells/mL in complete medium
(RPMI-1640 [Bio-Sciences], 1% glutamine [Sigma–
Aldrich], 1% nonessential amino acids [Sigma–Aldrich],
15% heat-inactivated foetal calf serum [Bio-Sciences], 1%
penicillin–streptomycin [Sigma–Aldrich]) and plated in
12-, 24- or 96-well plates (Greiner), depending on the
experiment.
MDM culture, stimulation and infection
For Experiment 3, plates were incubated for 7 days at
37°C, 5% CO2 to allow the maturation of monocytes into
macrophages as previously described (45). The culture
medium was changed every 2–3 days. From Day 3
onwards, antibiotic-free medium was used. At Day 6,
selected wells containing MDM were stimulated with
F. hepatica antigen by adding 20 lg/mL of FhES. For
FhES preparation, see Method S2 in Supporting Informa-
tion. At Day 7, M. bovis or M. bovis BCG was added at a
ratio of 1 : 1 (45) to selected wells containing either FhES
or PBS and then incubated for a further 24 h. PBS was
used as a negative control.
For flow cytometry experiments, at Day 7 PPDB (1 lg/
mL) (kindly provided by Prof. Eamon Gormley, UCD)
was added to selected wells, TLR2 as a positive control
(46). In all the cases, at least 3 wells were used for each
in vitro condition, with 3 unstimulated controls (PBS), 3
mycobacteria, 3 mycobacteria plus FhES and 3 FhES
wells, per animal.
Confirmation of bacterial infection of MDM
Ziehl–Neelsen staining was used to confirm intracellular
macrophage infection with M. bovis or M. bovis BCG (see
Method S2 and Figure S2 in Supporting Information).
Bacterial recovery from MDM (CFU)
In Experiment 3, for bacterial recovery from MDM,
mycobacterial colony-forming units (CFU) were calcu-
lated. When culturing M. bovis, agar plates were made
using Middlebrook 7H11 medium (DifcoTM, Becton
Dickinson) containing 10 mM of sodium pyruvate (Sigma–
Aldrich) and 10% ADC. For BCG-GFP culture in agar,
glycerol 1% (Sigma) was added instead of sodium pyru-
vate.
After removal of medium and extracellular bacteria
from the 96-well plates, cells were lysed by the addition of
65 lL of 0.1% Triton X-100 (Sigma–Aldrich) for 5 min.
Next, the lysates were serially diluted in Middlebrook 7H9
medium at concentrations from 102 to 104 before plat-
ing out in triplicate on agar plates. In parallel, 3 wells for
each condition and animal were used to count the number
of total macrophages in each well. After incubation of
agar plates for 4 weeks, colony counts were performed and
colony-forming units (CFU)/macrophage were calculated
using the formula:
CFU per macrophage = average of CFU in 3 agar
plates 9 200 lL (total volume of the dilution)/50 lL (vol-
ume used to plate out bacteria) 9 103 (dilution fac-
tor) 9 65 lL (volume of lysis buffer added to the well)/
20 lL (volume used to do the dilution)/number of macro-
phages in a well.
Bacterial uptake and receptor expression in MDM by
flow cytometry
Quality control measures
In Experiment 3, titration of antibodies for flow cytometry
was carried out by performing serial dilutions (1/20 to 1/
10 000) and selecting the optimal concentration in pilot
experiments. Instrument quality control was carried out
using Cytometer Setup and Tracking Beads (BD CS&T
beads), which were also used to standardize fluorescence
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across samples acquired on different days. Final voltage
settings were set using single-stained cell controls. For the
gating strategy and confirmation of consistency of the
results, fluorescence minus one controls (FMO) (cells con-
taining all fluorochromes except one) were used.
Unstained samples, as well as stained controls noninfected
and nonstimulated for each animal and each time point,
were included.
Harvesting of macrophages and viability staining
At Day 8 post-MDM culture (24 h post-BCG-GFP stimu-
lation), medium and extracellular bacteria were washed off
and macrophages were harvested by incubating cells for
10 min at 37°C with Accutase (Sigma). For the single posi-
tive control for viability dye, a mixture of dead/alive cells
was prepared, as per manufacturer’s instructions. Next,
50 lL of previously titrated viability dye (Fixable Viability
Dye eFluor 780, eBiosciences) (1/1000 in D-PBS) was
added to 50 lL of D-PBS containing the cells. Then, tubes
were incubated for 30 min at 2–8°C in the dark. After this,
the excess dye was washed off (D-PBS [cell culture grade,
Gibco], 3% heat-inactivated foetal calf serum [Gibco] and
0.09% sodium azide [Sigma–Aldrich], pH 7.5) and cell pel-
lets were incubated in 50 lL of blocking buffer (0.05 M Tris-
buffered saline, pH 7.4, containing 1% normal bovine
serum, 0.1% azide [Sigma–Aldrich] and 2% heat-inactivated
foetal calf serum [Gibco]) for 20 min at 4°C.
Antibody staining and cell fixation
TLR2 antibody CD282, a bivalent human recombinant
Fab antibovine antibody (AF 647 CD282 (AbD Serotec)),
was prepared at 1/10 dilution in staining buffer. CD14
antibody, a mouse anti-human antibody cross-reactive
with bovine (PerCP-Cy5.5 CD14 (BioLegend)), was
diluted 1/25 in staining buffer. Twenty-five microlitres
from each diluted antibody was added to 50 lL of block-
ing buffer containing cells, to have a final concentration of
1/40 for TLR2 and 1/100 for CD14 antibody. For detailed
antibody description, see Table S5 included in Document
S1 of Supporting Information. Then, tubes were incubated
at 4°C for 1 h. After washing cell pellets, those were fixed
in 100 lL of 1% paraformaldehyde in D-PBS for 1 h.
Then, 550 lL of staining buffer was added and tubes were
left overnight at 4°C until flow cytometry processing of
samples.
Instrument and data analysis details
A Beckman Coulter model Cyan ADP Lx flow cytometry
machine was used. The 488-nm laser was selected for FL1
(530/40-GFP) and FL4 (680/30 – PerCP-Cy5.5). The 635-
nm laser was used for FL8 (665/20 – Alexa Fluor 647)
and FL9 (750LP – eFluor 780).
Data were analysed with Beckman Coulter Summit
V4.03.02 Build 2451 software, and re-analysis was carried
out with Summit and De Novo Software FCS Express 4
RUO. Data files were kept as FCS data files, compensa-
tion was not required, and the gating applied was carried
out by including FMO controls which were the same cells
as used in the experiment. Gating was applied by selecting
target cells based on FSC vs. SSC plot, pulse width vs.
FSC area, SSC line vs. SSC area and LD (live death cells)
vs. FSC (Figure S3). The purity of monocyte-derived
macrophages was 99% as indicated by CD14 labelling.
The median of fluorescence intensities of each sample
obtained was normalized to its own unstimulated control,
resulting in a fold change value, so that BCG-stimulated
samples were comparable with Pre-F.hep and Post-F.hep.
For further information, see MIFlowCyt Standard in
Document S1.
mRNA analysis of MDM
mRNA extraction and cDNA transcription
In Experiment 3, for RNA extraction, the EZNA Total
RNA Kit 1 (OMEGA Bio-Tek) was used as per manufac-
turer’s instructions. For reverse transcription into cDNA,
500 ng of RNA was added to 12 lL of RNase-free water
(Sigma–Aldrich), containing 1 lL of oligo DT (0.5 lg/lL)
and 1 lL of 10 mM dNTP mix (Promega). A master mix
containing 1 lL of Moloney murine leukaemia virus
reverse transcriptase (MMLV-RT) (Biosciences), 4 lL of
first-strand buffer (59), 2 lL of 0.1 M DTT and 1 lL of
RNase OUT (40 U/lL) (Biosciences), per sample, was pre-
pared. Nonenzyme controls (no MMLV) and a nontem-
plate control (RNase-free water) were also prepared. Once
samples were incubated at 65°C for 5 min and at 4°C for
2 min, 8 lL of the master mix per vial was added. Sam-
ples were then incubated at 37°C for 50 min followed by
15 min at 70°C, and from then until the cDNA was fully
transcribed, kept at 4°C. cDNA samples were stored at
20°C until further processing.
qPCR. For real-time qPCR, all samples and controls
were included in duplicate. Nontemplate control and
nonenzyme control cDNA template were included for
each set of primers. Five nanograms of cDNA from
each sample was added to the qPCR plate containing
10 lL of SYBR Green PCR (29) (Applied Biosystems),
0.3 lL of the forward primer and 0.3 lL of the reverse
primer, and these were adjusted to a final volume of
20 lL with RNase-free water. A standard qPCR pro-
gram was used to run the reactions: 95°C for 1 min fol-
lowed by 40 cycles of 95°C for 15 s and 60°C for
1 min. A dissociation step was included for all reactions
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to confirm the presence of a single PCR product of the
expected size. Reference genes were established by carry-
ing out a GeneNorm analysis of 10 potential candidates
for internal controls. Reference target stability was
assessed across a set of 12 samples selected at random.
Results were analysed using the GeNorm qbasePLUS
software package (Biogazelle NV, Belgium) as described
by Hellemans et al. (47). Analysis determined peptidyl-
prolyl isomerase A (PPIA) to be the most stable target
gene for our samples with an M (gene expression stabil-
ity value) <0.02, and PPIA was included as internal con-
trol on all plates analysed. Intron-spanning primer was
designed for arginase I, iNOS, IL-6 and TGF-b using
the Primer3Plus package and synthesized commercially
(Eurofins MWG Operon, Ebersberg, Germany) (48):
(Arg1_fwd_180:50-CCAAGGTGTGTGGGAAAAGC-30;
Arg1_rev_180: 50-GATGTCCGTGTGAGCATCCA-30),
(iNOS_fwd: 50-AGAGACGGGGAGATCGGAAA-30;
iNOS_rev: 50-CATGCAGAGAACCTTGGGGT-30),
(IL-6_fwd: 50-ACGAAAGAGAGCTCCATCTGC-30;
IL-6_rev: 50-AATGGAGTGAAGGCGCTTGT-30),
(TGF-b_fwd: 50-ACAATTCCTGGCGCTACCTC-30;
TGF-b_rev: 50-ATTTCCTCTCTGCGGGTCAG-30)
Nitric oxide and cytokine production
In Experiment 3, nitric oxide (NO) production in MDM
supernatants was measured using the Griess reagent sys-
tem (Promega), according to the manufacturer’s instruc-
tions. IL-6, IL-1b and TGF-b were measured using the
ELISA kits for Bovine IL-6 (Cat: ESS0029, Thermo Scien-
tific), IL-1b (Cat: ESS0027, Thermo Scientific) and TGF-
b (Cat: G7590, Promega Corporation), according to the
manufacturer’s instructions. IL-12 was measured using
paired antibodies. A standard curve (Cat: RP0077B, King-
fisher Biotech) was included starting from 5000 ng/mL.
The working volumes were 100 lL/well, washing steps
were carried out with PBS-Tween three washes, and incu-
bation times were 1 h at room temperature unless other-
wise indicated. The capture antibody for IL-12
(MCA1782EL, AbD Serotec) was coated onto a 96-well
plate (8 lg/mL) and incubated at RT overnight. After this,
plates were washed and blocked using 1% BSA (Sigma–
Aldrich) in PBS-T. After the addition of the samples and
incubation, the detection antibody (MCA2173B, AbD Ser-
otec) was added (5 lg/mL). For the next step, strepta-
vidin-HRP (1 : 5000 dilution) (Invitrogen) was added and
incubated for 45 min and subsequently washed 5 times.
TMB was used to develop the colour under dark condi-
tions for 15 min. Finally, the reaction was stopped by the
addition of 1 N H2SO4 (Fisher Chemical), and the absor-
bance was read at 450 nm.
Statistical analysis
For co-infection studies (experiments 1 and 2), the response
variable Y for each animal (CFU) was defined as Y = log
(1 + total CFU) where total CFU denotes the sum of bacterial
CFU recovered from the left bronchial lymph node, the right
bronchial lymph node, the caudal mediastinal lymph node, the
cranial mediastinal lymph node and the cervical lymph node.
The treatment effect is the difference between the mean of Y in
animals co-infected vs. infected withM. bovis only. Data from
experiments 1 and 2 were combined, and analysis was carried
out by randomized block ANOVA, with ‘experiment’ as the
blocking factor on two levels. Firstly, the hypothesis that fluke
infection reduces mycobacterial load was tested. Secondly, we
tested the hypothesis that in co-infected animals, fluke count
was negatively associated with intensity of M. bovis infection.
A simple linear regression analysis adjusted for ‘experiment’
as a blocking factor on two levels was used to determine the
association between fluke count and M. bovis load and the
number ofM. bovis-positive tissues.
For Experiment 3, data were analysed using one-way
ANOVA for comparison of more than 2 groups and t-test
for comparison of 2 groups, using the software GraphPad
Prism 5. For qPCR data, relative gene expression fold
changes for each sample were calculated according to cali-
brated normalized relative quantities (CNRQ) utilizing the
qbasePLUS package (Eurofins MWG Operon).
RESULTS
Effect of F. hepatica infection on bacterial load in cattle
following aerosol challenge with M. bovis
For experiments 1 and 2, statistical analysis of bacterial bur-
den revealed that although the numbers of bacteria recovered
differed between the two experiments, there was no interaction
between treatment (co-infected orM. bovis only infected) and
experiment (P = 0.657). Combining the results of both experi-
ments, the totalM. bovis bacterial load was significantly lower
in co-infected animals (P = 0.0031), allowing for a significant
difference (P = 0.017) between experiments (Figure 1a). In
Experiment 1, all animals were confirmed positive for
M. bovis infection with either the qualitative or quantitative
technique, with the exception of 1 animal in the co-infected
group (26). In Experiment 2, all animals were confirmed posi-
tive in at least one tissue. The number of culture-positive
tissues was lower in the co-infected group; however, this was
not statistically significant (Figure 1b). We also compared the
number of liver flukes and bacterial load between animals;
however, there was no correlation (data not shown).
The distribution of infection identified through bacter-
ial culture was similar in both the M. bovis and the co-
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infected groups with the majority of bacteria recovered from
the bronchial, mediastinal and cervical lymph nodes (Tables
S3 and S4). A small number of additional isolates were
recovered from lung tissues (Experiment 2) in which small
(<1 cm in diameter) early-stage lesions were visible project-
ing from pleural surfaces with central cores of caseous
necrosis. Overall, no qualitative or quantitative differences
were observed in tuberculous lesions between the M. bovis-
infected and F. hepatica–M. bovis-infected animals. In both
treatment groups, after microscopical examination, lesions
exhibited varying degrees of central caseation necrosis with
contained foci of dystrophic mineralization. Necrotic cores
were bounded by layers of closely apposed macrophages,
macrophage giant cells and interspersed lymphocytes. This
layer in turn was surrounded by bands of fibrosis. While
there was some minor variation in the extent of these lesion
components, there was no major difference in these features
between the two groups (data not shown).
Effect of F. hepatica infection on IFN-c production in
animals co-infected with M. bovis
In co-infection experiments (experiments 1 and 2), IFN-c
production was measured in whole blood cultures after
stimulation in vitro with PPDB-PPDA and ESAT-6. In
Experiment 2, both groups responded with distinct increases
in IFN-c release after week 6 (2 weeks post-M. bovis infec-
tion) in response to PPDB-PPDA stimulation and these
increases were sustained throughout the experimental per-
iod. In the group co-infected with F. hepatica and M. bovis,
there was a noticeably reduced IFN-c response being statis-
tically significant at 7 and 20 weeks post-infection
(P < 0.05) (Figure 2a). Similarly, co-infected animals
showed a reduced IFN-c production in response to ESAT-6
which was statistically significant at 7, 17 and 22 weeks
post-infection (P < 0.05) (Figure 2b). These results are sim-
ilar to those of Flynn et al. (26) (Experiment 1).
The effect of F. hepatica infection on mycobacterial
recovery in monocyte-derived macrophages infected with
M. bovis and M. bovis BCG in vitro
In parallel, we used an in vitro study (Experiment 3) to
examine the effect of F. hepatica infection on bovine
monocyte-derived macrophages (MDM) in response to
M. bovis, M. bovis BCG-GFP and F. hepatica excretory/
secretory antigen (FhES). First, acid-fast (ZN) staining
was used to confirm mycobacterial infection of MDM
(Figure S2). Next, cultures of mycobacteria in agar plates,
obtained from lysed stimulated MDM were analysed. The
Figure 1 Effect of F. hepatica Infection on Bacterial Recovery in M. bovis-infected Cattle. For experiments 1 and 2, one group of 6 animals
in each was infected with 5 9 102 CFU M. bovis and the other 6 animals with 5 9 102 CFU M. bovis and 150 metacercariae from
F. hepatica. Tissues were recovered, homogenates were cultured onto 7H11-OADC agar plates, and CFU were counted per gram of tissue,
to obtain the quantitative value. CFU were transformed to Y = (1 + total CFU). Data from experiments 1 and 2 were combined, and
analysis was carried out by randomized block ANOVA, with ‘experiment’ as the blocking factor on two levels. Co-infected animals (F. hep-
Mb) showed a reduced total bacterial recovery in comparison with those infected with M. bovis only (Mb). ** means P = 0.0031 with a
95% confidence interval 9.083  5.446 (a). For qualitative culture, tissue homogenates were cultured into the BACTEC MGIT 960
system, which gave a positive or negative result. In Experiment 1, all animals were culture positive with the exception of 1 in the M. bovis–
F. hepatica group (Flynn et al. (2009)). In Experiment 2, all animals were confirmed infected with M. bovis with either the qualitative or
quantitative technique (b). Co-infected animals showed a reduction in the number of M. bovis culture-positive tissues; however, the
differences were not statistically significant (ns) (b). White or black squares correspond to each animal of Experiment 1 or Experiment 2,
respectively. Dashed lines (Experiment 1) or black lines (Experiment 2) indicate the mean CFU per gram of tissue (a) or mean number of
M. bovis culture-positive tissues (b). See Table S3 and Table S4 for detailed information in the bacterial counts.
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mean number of M. bovis recovered from cultures prior to
F. hepatica infection was 6 colony-forming units (CFU)
per macrophage, which decreased to 4 CFU per macro-
phage 10 week post-F. hepatica infection. At this time
point, the numbers of M. bovis recovered from MDM
co-stimulated with FhES decreased further to 2 CFU per
macrophage, which was significantly different in compar-
ison with before F. hepatica infection (P < 0.05) (Fig-
ure 3a). Four weeks post-F. hepatica infection, bacterial
recovery tended to be lower than prior to F. hepatica
infection also; however, differences were not statistically
significant. In the same way as described for M. bovis, the
nonvirulent BCG-GFP was cultured in agar plates. A
reduction in the numbers of BCG-GFP recovered (CFU)
was seen 10 weeks post-F. hepatica infection (P < 0.05);
in this case, the addition of FhES did not alter these
numbers (Figure 3b).
The Effect of F. hepatica Infection on Bacterial Uptake
and TLR2–CD14 Expression in Macrophages Infected
with BCG-GFP in vitro
Next, we used flow cytometry to investigate whether bac-
terial uptake and surface receptor expression in MDM
would be modified by F. hepatica infection. At 8 weeks
post-F. hepatica infection, the fluorescence intensity of
BCG-GFP-infected MDM was shifted towards the left,
indicating a reduction in fluorescence intensity (Fig-
ure 4a). However, the fluorescence intensity of TLR2 and
CD14 receptors from BCG-GFP-infected MDM moved to
the right after F. hepatica infection, indicating an increase
in fluorescence intensity (Figure 4b, c).
Statistical analysis of the data from all animals showed
that after F. hepatica infection, bacterial uptake was lower
than before F. hepatica infection (P < 0.05) (Figure 4d).
(a)
(b)
Figure 2 Effect of F. hepatica Infection on
IFN-c production in M. bovis-infected
Cattle. For co-infection experiments IFN-c
release was measured from whole blood
cultures following stimulation with PPDB-
PPDA or ESAT-6. Results (Net OD) were
calculated from PPDB minus PPBA, with
positives indicated by the value for PPDB
greater than 0.1 OD and PPDB-PPDA
greater or equal to 0.05 OD (a). In (b), Net
OD was calculated from ESAT-6 minus
PBS, with positives indicated by a value
>0.05 OD. Co-infected animals with
F. hepatica and M. bovis (squares) showed a
reduced response to the mycobacterial
antigens in comparison with only M. bovis-
infected animals (circles). * = P < 0.05.
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On the contrary, TLR2 expression following F. hepatica
infection was increased and statistically significant when
MDM were restimulated with FhES in vitro (Figure 4e).
In the case of CD14, its increased expression after F. hep-
atica infection was statistically significant (P < 0.05)
regardless of the addition of FhES (Figure 4f). Neverthe-
less, these surface receptors and bacterial uptake did not
show a statistically significant inverse correlation (data not
shown).
The effect of F. hepatica infection on macrophage
activation and cytokine profile
We hypothesized that reduced mycobacterial recovery after
F. hepatica infection of cattle could be associated with an
alteration in the activation of macrophages and their cyto-
kine profile. To study such modification in macrophage
phenotype, we measured arginase and nitric oxide produc-
tion, markers of alternative and classical activation,
respectively. MDM showed upregulated arginase I mRNA
expression at 10 week after F. hepatica infection
(P < 0.05) (Figure 5a). However, as expected, there was a
downregulation in iNOS mRNA expression (fold change
of 5500) (P < 0.05) and nitric oxide production (P < 0.01)
in M. bovis-stimulated MDM after F. hepatica infection
(Figure 5b, c). Next, we investigated the levels of a panel
of cytokines. The levels of pro-inflammatory cytokines IL-
1b, IL-12 and IL-6 were reduced after F. hepatica infec-
tion (P < 0.001, P < 0.01 and P < 0.05, respectively),
whereas TGF-b was increased after F. hepatica infection
(P < 0.05) (Figure 6).
DISCUSSION
We have previously described reduced responsiveness to
M. bovis diagnostic tests (SICCT test and the IFN-c test)
in cattle co-infected with F. hepatica (26). However, to
date, there has been no evidence to link this effect to bac-
terial load or disease dynamics. Given the substantial
resources expended in national control programmes for
bovine tuberculosis, which rely on those immunodiagnostic
tests, any such interactions warrant further study.
Thus, one of our objectives was to study the effect of
F. hepatica on bacterial load from M. bovis-infected ani-
mals. Helminth-mediated immunoregulation is a multifac-
torial phenomenon, with macrophage-mediated effects one
of the principal facets involved. As macrophages are also
key elements in the progress of and response to mycobac-
terial infections, we chose also to study changes in macro-
phages. Previous co-infection studies have shown that
Schistosoma mansoni (27) and Nippostrongylus brasiliensis
(14) co-infection in mice increased the bacterial burden
and growth of M. tuberculosis, respectively. F. hepatica
infection in cattle induced higher excretion rates in concur-
rent infection with Salmonella Dublin and more dissemi-
nated bacterial infection in the organs (15). Similarly,
another study in mice showed that co-infection with
F. hepatica and Bordetella pertussis delayed bacterial
Figure 3 Effect of F. hepatica Infection on Recovery of M. bovis and M. bovis BCG-GFP from MDM. For Experiment 3, MDM were
isolated from cattle before, and 4 week and 10 week after F. hepatica infection and then incubated with M. bovis (Mb) (a) or BCG-GFP
(b) (MOI 1 : 1) in vitro for 24 h or added to MDM previously stimulated with FhES (ES) (20 lg/mL) for 24 h. Cultures in 7H11-OADC
agar plates of mycobacteria show that 10 weeks post-F. hepatica infection, M. bovis recovery per macrophage was lower than before
F. hepatica infection, although this was not statistically significant until after co-stimulation with FhES (*=P < 0.05) (a). Similarly, lower
numbers of BCG-GFP were recovered 10 weeks post-F. hepatica infection either with or without FhES restimulation (*=P < 0.05) (b). The
CFU per macrophage were calculated, with three replicates per animal (represented as different symbols). Horizontal lines represent the
mean CFU per macrophage  SEM, n = 6.
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clearance in the co-infected groups (16). Thus, based on
our previous (26) results demonstrating reduced Th1
responses, with reduction in M. bovis-induced IFN-c pro-
duction in animals co-infected with F. hepatica (Figure 2),
we hypothesized that mycobacterial recovery and uptake
would be enhanced in the presence of the helminth infec-
tion. In contrast, however, the opposite was observed, with
reduced mycobacterial burden directly recorded from the
tissues of co-infected animals (Figure 1). Our data also
show that bacterial recovery from MDM infected with
M. bovis in vitro was reduced after helminth infection
(Figure 3). Additionally, given that F. hepatica ES antigen
(FhES) is able to induce the production of Th2 and Treg
cytokines as well as arginase (25,49), we suggested that
FhES could further influence such mycobacterial uptake
and survival. In this case, the addition of FhES to
macrophages further decreased M. bovis survival (Fig-
ure 3a). However, when the nonvirulent M. bovis BCG
was used for the experiments (Figure 3b and Figure 4d),
the addition of FhES did not result in any further differ-
ences in bacterial uptake or recovery in comparison with
the BCG-only-stimulated cells. This could be explained
because M. bovis BCG uptake and growth is much lower
than when M. bovis is used (45), so a subtle further differ-
ence added with FhES may not have been detected.
Nevertheless, the finding of lower mycobacterial uptake
and recovery after F. hepatica infection of cattle is in line
with some previous studies. It has been shown that rats
co-infected with the nematode Litomosoides sigmodontis
and M. tuberculosis had lower bacterial loads than rats
with M. tuberculosis infection only (50). Likewise, another
study demonstrated that acute Nippostrongylus brasiliensis
(a) (b) (c)
(d) (e) (f)
Figure 4 Effect of F. hepatica Infection on Bacterial Uptake, TLR2 and CD14 Receptor Expression by MDM. In Experiment 3, MDM
isolated from cattle prior to and 8 weeks post-F. hepatica infection were stimulated in vitro with BCG-GFP (MOI 1 : 1) for 24 h or FhES
(20 lg/mL) (ES) for 48 h. Then, MDM were collected and stained with the antibodies Alexa Fluor 643 TLR2 and with PerCP-Cy5.5
CD14 and analysed with flow cytometry. In the overlaid univariate histograms, a representative sample stimulated with BCG-GFP shows a
shift towards the left in fluorescence intensity after F. hepatica infection of cattle (a). However, there is a shift towards the right when the
CD14 and TLR2 receptors were measured after F. hepatica infection (b, c). Y-axis indicates cell count and the x-axis indicates median
fluorescence intensity. Nonfilled histogram = Post-F. hepatica infection; filled line histogram = Pre-F. hepatica infection. A minimum of
6 9 104 single cells have been recorded and analysed per sample (sample = biological replicate) (a–c). Statistical analysis of all samples
from the 6 animals shows that at 8 week post-F. hepatica infection, bacterial uptake is reduced in MDM (d); however, TLR2 (e) and CD14
(f) receptor expression was maintained or increased. Each symbol with the same shape represents the average of 3 biological replicates of
each animal. The median of fluorescence intensity obtained from the histograms was normalized to the unstimulated controls, and results
were expressed as the mean  S.E.M (d–f). *P < 0.05, n = 6. For gating strategy, see Figure S3.
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(Nb) infection in mice reduced early pulmonary mycobac-
terial colonization (11). Additionally, other studies have
shown decreased M. tuberculosis–GFP uptake in human
DC when they were pre-exposed to microfilaria (51). Next,
we investigated a potential cause of this lowered bacterial
uptake, the receptors TLR2 and CD14. TLR2 is one of
the pathogen-recognition receptors (PRRs) on the surface
of macrophages which recognize pathogen-associated
molecular patterns (PAMPs) from mycobacteria (52,53).
TLR2 together with its co-receptor CD14 has been associ-
ated with recognizing and triggering mycobacterial
immune responses (31,32). Sendide et al. (2005) showed
that in THP-1 and CHO cell lines, optimal M. bovis BCG
uptake required the presence of both CD14 and comple-
ment receptor 3 (CR3) and co-expression of CD14 and
TLR2 markedly enhanced such uptake (28). In bovine
macrophages, Souza et al. (2007) demonstrated that man-
nose receptors and CD14 contributed to Mycobacterium
avium phagocytosis (29). Blocking TLR2 receptors in
bovine macrophages enhanced killing of Mycobacterium
avium paratuberculosis by enabling phagosome maturation
within the cell (30). Hence, we might have expected that
lower bacterial uptake would be associated with reduced
expression of TLR2 and CD14 after F. hepatica infection
of animals. However, expression of TLR2 and CD14 was
conserved or enhanced in F. hepatica-infected animals
(Figure 4b, c, e, f). In agreement with those findings, how-
ever, other studies have also shown enhancement of TLR2
expression following helminth infection (33,54). For exam-
ple, schistosome-specific phosphatidylserine (PS) activated
TLR2 in dendritic cells (55). In another study, dendritic
cells and B cells from Schistosoma mansoni infected
patients with multiple sclerosis, stimulated with soluble egg
Ag (SEA), resulted in significant TLR2 upregulation (33).
Given this inverse correlation between TLR2–CD14
expression and bacterial uptake, we examined other mech-
anisms involved in lower mycobacterial uptake by macro-
phages in the context of F. hepatica infection. For this, we
studied the activation phenotype of macrophages after
F. hepatica infection. Our results show that M. bovis-sti-
mulated MDM had upregulated mRNA expression of
arginase I but downregulated mRNA expression of iNOS,
which was associated with lowered production of nitric
oxide (Figure 5). Previously, it has been demonstrated that
F. hepatica infection and F. hepatica products elicit alter-
native activation of peritoneal macrophages (56) and of a
ruminant macrophage cell line (34). These alternatively
activated macrophages, known to develop in F. hepatica
Figure 5 Effect of F. hepatica Infection on
Macrophage Activation. For Experiment 3,
MDM were isolated from cattle before and
10 week after F. hepatica infection and then
incubated with M. bovis (Mb) (MOI 1 : 1)
in vitro for 24 h or left unstimulated. qPCR
results show that arginase I mRNA in
MDM was upregulated after F. hepatica
infection of cattle, in both unstimulated
MDM and after Mb stimulation. However,
there was a downregulation in iNOS mRNA
expression in Mb-MDM after F. hepatica
infection (c) which coincided with reduction
in nitric oxide production (b). * = P < 0.05,
** = P < 0.01. Results express mean  SEM
of relative fold change of mRNA (a,c) or lM
nitric oxide (b), n = 6.
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infections (34,35), are not as efficient in phagocytosing
bacteria as classically activated macrophages. For example,
Varin et al. (2010) showed low uptake of Neisseira menin-
gitidis after IL-4 and IL-13 stimulation of murine macro-
phages which was related to alternative activation of
macrophages (36). As our study shows such phenotype
switching after F. hepatica infection (Figure 5), alternative
activation of macrophages could be the reason for a lower
bacterial uptake. Additionally, another group found that
F. hepatica fatty acid binding protein (FABP) induced
alternative activation of human macrophages and reduced
production of the pro-inflammatory cytokine IL-1b by
MDM after LPS stimulation (57). Likewise, we have
demonstrated a diminution in IL-1b in MDM stimulated
with M. bovis after F. hepatica infection (Figure 6a). In
mycobacterial infections, IL-1b has been described as
essential for recruiting immune cells to the site of infection
(58). In addition, IL-1b is involved in direct activation of
Figure 6 Effect of F. hepatica Infection on
Macrophage Cytokine Profile. For
Experiment 3, MDM were isolated from
cattle before and 10 week after F. hepatica
infection of cattle and then incubated with
M. bovis (Mb) (MOI 1 : 1) in vitro for 24 h
or left unstimulated. The levels of cytokines
IL-1b, IL-12, IL-6 and TGF-b in MDM
cultures were measured by ELISA (a–c, e)
or qPCR (d, f). There was a decrease in the
production of IL-1b (a), IL-12 (b) and IL-6
in Mb-MDM after F. hepatica infection (c).
Similarly, IL-6 mRNA expression in Mb-
MDM was downregulated (d). However,
TGF-b production (e) and TGF-b mRNA
expression (f) in MDM were increased after
F. hepatica infection. * = P < 0.05, ** =
P < 0.01, **** = P < 0.001. Results express
mean  SEM of pg/mL (a–c, e) or relative
fold change of mRNA (d, f). n = 6.
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humoral immune responses (59), antigen presentation, and
expansion and recruitment of T cells to the skin, which in
consequence promotes local inflammation in delayed-type
hypersensitivity responses (40). As our data show that
IL-1b production by M. bovis-infected MDM is reduced
when animals are infected with F. hepatica, this could
indicate that in co-infected animals, the responsiveness to
the SICCT, which is based on a delayed-type hyperse-
nsitivity reaction, would be reduced. Moreover, IL-12
together with IL-1b is able to induce IFN-c production in
Th1 lymphocytes (37,38). As we have found that M. bovis-
stimulated MDM produced less IL-12 after F. hepatica
infection (Figure 6b), this could explain why blood cul-
tures from co-infected animals with F. hepatica had lower
IFN-c production than those infected with M. bovis only
(Figure 2) (25,26). Our results also show a reduction in
IL-6 production by MDM after F. hepatica infection of
cattle. Among the multiple functions of IL-6, it has been
described to be a marker for M. tuberculosis infection in
mouse peritoneal macrophages (60). In addition, IL-6 has
been associated with inhibition of type I interferon, which
is involved in disease progression (61) and with differentia-
tion of T cells to the Th17 phenotype (62,63), which con-
tributes to Th1 response expansion (64–66). A reduction
in IL-6 production after F. hepatica infection, as shown in
our study (Figure 6c, d), would potentially affect bacterial
burden, and granuloma formation in M. bovis and BCG
infections (64–66). On the other hand, our results show an
increase of TGF-b in MDM after F. hepatica infection.
This regulatory cytokine has been found to be produced
in F. hepatica-infected cattle, in PBMC stimulated with
F. hepatica LFH (liver fluke homogenate) (67). In another
study, peritoneal macrophages from na€ıve mice produced
TGF-b, IL-10 and arginase I after in vitro stimulation with
F. hepatica ES as well as after F. hepatica infection of
mice (68). In the context of F. hepatica and mycobacterial
co-infection, TGF-b would downregulate the type 1
responses elicited against the bacterial infection. Indeed, a
study with humans immunized with M. bovis BCG showed
that concurrent helminth infection produced greater levels
of TGF-b, which was associated with reduced response to
the immunization, affecting vaccine efficacy (69).
In our studies, in summary, bovine MDM infected
ex vivo with M. bovis showed strikingly reduced production
of IL-6, IL-1b, IL-12 and NO after donor animals were
infected with F. hepatica infection. As it has been shown
that INF-c production in response to mycobacterial infec-
tion is dependent on IL-6, IL-1b and IL-12 (37,38,70,71),
this could explain the reduced IFN-c production observed
when animals were infected with F. hepatica in the co-
infection experiments (Figure 2) (25,26). Additionally, the
fact that IL-1b promotes local inflammation in delayed-
type hypersensitivity responses (40) indicates that a reduced
production of IL-1b in F. hepatica-infected animals could
cause a lowered SICCT test reaction in those animals
(25,26). Based on these results, we propose that early in the
course of M. bovis infection, alternatively activated macro-
phages limit the uptake of mycobacteria, setting the stage
for a slower rate of bacterial proliferation and lesion devel-
opment, leading to a reduced pro-inflammatory response.
In fact, Atkinson et al. (2000) showed that production of
TNF-a, IL-12, IL-6 and IL-10 by human MDM was
dependent on the M. bovis BCG dose used, so that lowered
bacterial dose reduced cytokine production (72). As macro-
phages produce cytokines upon stimulation (73), a reduced
stimulus elicited by an inefficient phagocytosis (in our case
lowered M. bovis uptake) could decrease a pro-inflamma-
tory response (74). Therefore, we hypothesize that this
immune downregulation may induce a latency-like state in
co-infected animals, which would explain why cattle herds
with high prevalence of fasciolosis would have lower reac-
tivity in tests for BTB. This hypothesis is consistent with
the data on an epidemiological scale shown by Claridge
et al. (2012) who showed the under-ascertainment rate
of BTB was about one-third in herds infected with
F. hepatica (6).
Latent infections with M. tuberculosis in humans are
extremely common, with some estimates indicating that up
to one-third of the world’s population are latently infected
(19), representing a reservoir from which clinically apparent
infections can emerge, given appropriate environmental cir-
cumstances. Latent infection is characterized by asymp-
tomatic, chronic infection, with lowered responsiveness to
skin testing (75). Latent M. bovis infections in cattle have
not been described. However, the presence of such infec-
tions in cattle is suggested by findings such as IFN-c test
(23,76) and skin test positivity (77,78) in animals that lack
lesions at post-mortem; the positive culture of bacteria in
animals without lesions (44,79); and IFN-c positive and
skin test negative animals, which later convert to positive,
that have lesions at post-mortem examination (78). Studies
on the influence of concurrent helminth infections on
latent/active tuberculosis in humans have given contradic-
tory results. Babu et al. (2009) observed a reduction in
mycobacterial-specific TLR2 and TLR4 expression as well
as a decrease in pro-inflammatory production in individu-
als with filariasis/TB in comparison with patients with TB
only (8). However, subsequent studies by this group
observed no alteration in the incidence of progression from
latent to active tuberculosis in populations co-infected with
gastrointestinal and/or filarial nematodes (80).
Such apparent paradoxes can be resolved by consider-
ing that helminth infection limits the pro-inflammatory
environment, favouring a slower development of
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mycobacteria, with reduced bacterial loads, but a higher
diagnostic barrier for immune-based detection assays.
This may ensure a strategy to maintain M. bovis in the
population by increasing the reservoir of undetected
infection. Therefore, these findings have significant impli-
cations for the control of bovine TB and especially
for eradication programmes based on detection and
slaughter of infected animals.
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SUPPORTING INFORMATION
Additional Supporting Information
may be found online in the support-
ing information tab for this article:
Table S1. Fasciola hepatica numbers.
At post-mortem examination of cattle
(Experiment 2), livers were processed
and liver flukes counted, confirming
F. hepatica infection in all 6 animals.
Table S2. Mycobacterial dose
obtained by side-flow sampling in
Madison Chambers. During infection
with M. bovis, side-stream samples of
air were taken from the Madison
Chamber, and then M. bovis was cul-
tured to determine the actual dose
(CFU) delivered to each individual ani-
mal. There were no statistically signifi-
cant differences between the bacterial
doses delivered to the calves between
groups. In brackets is represented the
standard deviation.
Table S3. Experiment 1_Isolation of
M. bovis from tissues recovered from
calves infected with M. bovis only or
M. bovis and F. hepatica. There was a
decrease in the total bacterial load and
total number of positive tissues recov-
ered in the M. bovis–F. hepatica co-
infected group in comparison with the
M. bovis infected group only. Results
are expressed as 101 9 CFU/g (quan-
titative counting).
Table S4: Experiment 2_Isolation of
M. bovis from tissues recovered from
calves infected with M. bovis and
F. hepatica (a) or M. bovis only (b).
There was a reduced bacterial load
recovery and number of positive tis-
sues (by quantitative or qualitative
bacteriology) in theM. bovis–F. hepat-
ica co-infected group vs. the only
infected with M. bovis. When the same
tissue was positive in both techniques,
it was counted as positive only once.
aQL – Qualitative bacteriology (BAC-
TEC MGIT system). bQN – Quantita-
tive bacteriology (7H11-OADC agar
plates). cResults expressed as 9 101
CFU/g
Figure S1. Seroconversion of F. hep-
atica Infected Cattle.
Figure S2. Confirmation of MDM
infected with mycobacteria in vitro
Figure S3.Gating strategy.
Method S1. F. hepatica Excretory/
Secretory Products (FhES)
Method S2. Acid Fast Staining
Document S1. Experiment Annota-
tion Using MIFlowCyt Standard
Table S5. Description of antibodies
and lasers used.
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